Condition: Chronic Pelvic Pain · Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease
This description comes directly from the study's public registry record.
Xiuxiang Teng · +86 010-87906734 · tengxx@126.com
Always discuss trial participation with your own doctor first.
| Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05970783